Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SBC
stocks logo

SBC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent
Wall Street analysts forecast SBC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SBC is 9.00 USD with a low forecast of 9.00 USD and a high forecast of 9.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast SBC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SBC is 9.00 USD with a low forecast of 9.00 USD and a high forecast of 9.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.750
sliders
Low
9.00
Averages
9.00
High
9.00
Current: 3.750
sliders
Low
9.00
Averages
9.00
High
9.00
Maxim
Maxim
initiated
$9
2025-11-05
Reason
Maxim
Maxim
Price Target
$9
2025-11-05
initiated
Reason
Maxim initiated coverage of SBC Medical Group with a Buy rating and $9 price target.
See All Ratings

Valuation Metrics

The current forward P/E ratio for SBC Medical Group Holdings Inc (SBC.O) is 7.92, compared to its 5-year average forward P/E of 3.68. For a more detailed relative valuation and DCF analysis to assess SBC Medical Group Holdings Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
3.68
Current PE
7.92
Overvalued PE
7.82
Undervalued PE
-0.46

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.16
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.85
Undervalued EV/EBITDA
-0.53

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.12
Current PS
0.00
Overvalued PS
2.33
Undervalued PS
-0.09
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

SBC News & Events

Events Timeline

(ET)
2025-11-14
07:50:14
SBC Medical Group Signs Consulting Deal with Blez Asia
select
2025-11-14
07:28:09
SBC Medical Group announces Q3 earnings per share of 12 cents, surpassing consensus estimate of 11 cents.
select
2025-08-13 (ET)
2025-08-13
06:56:35
SBC Medical Group reports Q2 EPS 2c vs. 20c last year
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.5
12-04Globenewswire
PinnedBrompton Split Banc Corp. Successfully Raises $38.2 Million in Preferred Shares Offering
  • Successful Financing: Brompton Split Banc Corp. has successfully raised approximately $38.2 million through a preferred shares offering, strengthening its capital base to support future investments.
  • Offering Details: The preferred shares were offered at $10.40 each with a yield of 6.0%, providing investors with a stable return expectation, which is likely to attract more investor interest.
  • Underwriting Team: The offering was led by prominent financial institutions including RBC Capital Markets, showcasing market confidence and support for the fund, thereby enhancing the company's market reputation.
  • Portfolio Diversification: The fund invests approximately 50% of its assets in common shares of the six largest Canadian banks and may hold up to 10% in global financial companies, aiming to enhance portfolio diversification and return potential.
[object Object]
Preview
8.0
11-21Globenewswire
Brompton Funds Announce Distributions for Split Share Fund

  • Distribution Announcement: Brompton Funds will pay distributions on December 12, 2025, to class A shareholders of several funds, including Dividend Growth Split Corp. and Brompton Energy Split Corp., with amounts ranging from $0.075 to $0.10 per share.

  • Preferred Shareholder Distributions: Preferred shareholders of Dividend Growth Split Corp. will receive a distribution of $0.16875 per share, also payable on December 12, 2025.

  • Net Asset Value Conditions: The announcement of distributions for Brompton Energy Split Corp. is contingent upon the net asset value per unit being above $15.00 and the preferred shares not being in arrears.

  • Investment Fund Information: Brompton Funds, established in 2000, offers various investment solutions and encourages class A shareholders to enroll in distribution reinvestment plans (DRIP) for automatic reinvestment of distributions.

[object Object]
Preview
3.0
11-14NASDAQ.COM
Earnings Report Ahead of Market Opening for November 14, 2025: SR, SRRK, TWST, BTBT, SGML, FRGE, SBC, GAUZ, INKT, MRSN, ITRM, LMFA

  • Earnings Reports Overview: Several companies, including Spire Inc., Scholar Rock Holding Corporation, and Twist Bioscience Corporation, are set to report their earnings for the quarter ending September 30, 2025, with varying forecasts for earnings per share (EPS) and growth compared to the previous year.

  • Spire Inc. Performance: Spire Inc. is expected to report an EPS of $-0.46, reflecting a 14.81% increase year-over-year, with a Price to Earnings (P/E) ratio of 20.08, indicating stronger growth potential than its industry peers.

  • Scholar Rock Holding Corporation and Twist Bioscience: Scholar Rock is forecasted to have an EPS of $-0.88, a 33.33% decrease from last year, while Twist Bioscience anticipates an EPS of $-0.40, a 32.20% increase, despite missing previous earnings expectations.

  • Other Notable Companies: Companies like Bit Digital, Sigma Lithium, and SBC Medical Group are also reporting, with SBC Medical expected to show significant growth with a 333.33% increase in EPS, while others like MiNK Therapeutics and Mersana Therapeutics are facing declines in their EPS forecasts.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is SBC Medical Group Holdings Inc (SBC) stock price today?

The current price of SBC is 3.75 USD — it has decreased -0.79 % in the last trading day.

arrow icon

What is SBC Medical Group Holdings Inc (SBC)'s business?

SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

arrow icon

What is the price predicton of SBC Stock?

Wall Street analysts forecast SBC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SBC is 9.00 USD with a low forecast of 9.00 USD and a high forecast of 9.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is SBC Medical Group Holdings Inc (SBC)'s revenue for the last quarter?

SBC Medical Group Holdings Inc revenue for the last quarter amounts to 43.35M USD, decreased -18.33 % YoY.

arrow icon

What is SBC Medical Group Holdings Inc (SBC)'s earnings per share (EPS) for the last quarter?

SBC Medical Group Holdings Inc. EPS for the last quarter amounts to 0.12 USD, increased 300.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for SBC Medical Group Holdings Inc (SBC)'s fundamentals?

The market is revising Downward the revenue expectations for SBC Medical Group Holdings Incorporated (SBC) for FY2025, with the revenue forecasts being adjusted by -2.33% over the past three months. During the same period, the stock price has changed by -9.64%.
arrow icon

How many employees does SBC Medical Group Holdings Inc (SBC). have?

SBC Medical Group Holdings Inc (SBC) has 863 emplpoyees as of December 05 2025.

arrow icon

What is SBC Medical Group Holdings Inc (SBC) market cap?

Today SBC has the market capitalization of 384.66M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free